The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ: CROX) ("Crocs" or the "Company") on ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.73% of ...

Crocs (CROX) closed the most recent trading day at $103.89, moving -1.17% from the previous trading session. This change lagged the S&P 500's 1.83% gain on the day. Elsewhere, the Dow gained 1.65%, ...

The stock price decline from the lower-than-expected guidance presented an even more attractive price for patient investors.

Momentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or ... of all age. CROX is a #3 ...

Crocs' struggles with HEYDUDE acquisition impact stock returns, but strong core brand and improving debt position hint at ...

In the latest market close, Crocs (CROX) reached $109.68 ... adjustments in estimates directly associate with imminent stock price performance. To exploit this, we've formed the Zacks Rank ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

Check the time stamp on this data. Updated AI-Generated Signals for Crocs Inc. (CROX) available here: CROX. Type a few ...

Williams Trading downgraded Crocs (CROX) to Hold from Buy with a $112 price target Stay Ahead of the Market:Discover outperforming stocks and ...